Dr. Shirk is a Principal Regulatory Writer, with 10 years of regulatory writing experience of nonclinical and clinical regulatory documents for small-molecule drugs and biologics across multiple therapeutic areas. In addition, she has 8 years of experience in pharmaceutical research and development and 13 years of experience in clinical laboratory science as a board-certified medical technologist. She leads nonclinical writing teams for INDs, NDAs, and BLAs, serving as a liaison between writers, client, and management; maintaining collaborative and proactive communications with both client and internal team; and providing guidance and critical reviews.She develops, manages, and authors regulatory documents according to regulatory guidelines and ensures adherence to high quality standards, timeline, and budget, while managing multiple writing projects. She has extensive writing experience with CTD modules 2.4 and 2.6 (nonclinical overview and nonclinical summaries), modules 2.7.1 and 2.7.2 (summaries of biopharmaceutic studies and clinical pharmacology), and investigator brochures.